GS-441524 – Pain In The Bud

Starting on June 1, people whose cats are infected with deadly Feline Infectious Peritonitis won’t have to shell out thousands of dollars to shady middlemen importing the cure from China.

FIP is a virtual death sentence for cats, but there’s a drug — GS-441524 — that has a cure rate somewhere around 90 percent, a Godsend for people whose beloved felines are afflicted with the virus.

Previously the only way to get it was through predatory online middlemen who charged exorbitant sums, but thanks to a partnership between UK pharmaceutical company Bova Group and New Jersey-based compounding pharmacy Stokes, the FIP cure will be available legally in the US.

The legal version of the drug will come in a tuna-flavored tablet format and customers can expect to pay a few hundred dollars for a full treatment instead of between $5,000 and $15,000 some paid for the FIP treatment from importers.

A US company invented the drug and held the rights, so it seemed like bringing it to market for cat caretakers would be a no-brainer. Unfortunately, GS-441524 is similar to COVID drug Remdesivir so the company was worried if they submitted the FIP cure to the FDA for approval and the FDA did not grant it, the denial could lead the agency to revoke its approval of Remdesivir due to its molecular similarity.

As a result, innumerable people whose cats were suffering with FIP turned to groups like Facebook’s FIP Warriors to help them obtain GS-441524 illegally. The drug was manufactured by facilities in China, sold to middlemen in the US and Europe, then marked up by eye-watering amounts for sale to people with sick cats.

jupiterpitbtopimg — Jupiter, a British shorthair, was diagnosed with FIP. His human, a young professional from London, paid almost $10,000 for FIP treatment obtained through middlemen.

Last year the feds announced they’d exposed a GS-441524 smuggling ring, alleging a woman from Texas and another from Oregon had made almost $10 million from selling the FIP treatment to panicked cat lovers.

GS-441524 importers knew their customers were desperate to save their beloved feline friends so they’d be willing to pay the extraordinary mark-up — and pay they did.

Here at PITB we’ve interviewed and written about several people whose cats were diagnosed with FIP. One of them, a student, spent her entire savings on GS-441524 obtained through the Facebook group and relied on help from generous donors to raise the rest. Another, a young professional in London, paid even more, spending £7,500 (about $9,400 at the time) on the medication alone, not including vet visits.

A Texas woman whose cat, Seth, was diagnosed with FIP said the middlemen — and women — said the sellers “saw our desperate situation and took advantage of us.”

“It was a very stressful time for us, and every time we needed to refill, they charged us more,” she told PITB. “They knew we couldn’t say no.”

For readers interested in more details about GS-441524, Stokes pharmacy has a resource page that breaks down pricing, shipment times, availability and more.

Parsnip, the cat pictured at the top, and Jupiter, the British shorthair pictured within the story, were both cured after taking full courses of GS-441524.

FIPV is pretty much a guaranteed death sentence for cats, and the only way to cure it is with an experimental drug that doesn’t have FDA approval.

Oregon’s Nancy Ross and Nicole Randall of Texas knew that, and as importers selling the cure via the popular Facebook group FIP Warriors, the FDA says they banked on the desperation of people who would do almost anything to save their cats — including forking over vast sums of money.

Ross and Randall are now accused by the FDA of smuggling GS-441524 from China, where it’s manufactured illegally, and hiking the price by almost 16 times what they paid for it as they served as the middle women between desperate cat owners and the suppliers in Hong Kong.

Feline infectious peritonitis kills some 95 percent of cats it infects, and veterinarians often tell their clients with FIPV cats that while they can’t prescribe GS-441524, they will help administer it, track their cats’ progress through bloodwork and hopefully save feline lives — if the clients obtain the drug themselves.

FIP Warriors — now in its fifth incarnation as FIP Warriors 5.0 on Facebook — is where people with FIPV cats go to find suppliers. The group has more than 43,000 members, and the FDA says Randall made millions off of them, charging as much as $385 for vials of GS-441524 she obtained for between $25 and $45 from manufacturers in Hong Kong and mainland China.

Randall sold $9.6 million worth of GS-441524 to clients in the US, according to the FDA. Per The Oregonian:

“A spreadsheet found in Randall’s Google email showed customer orders of at least 58,460 vials and 236,836 pills of GS-441524 from July 2020 through June 6, 2022, the affidavit said.”

PITB spoke to several people who paid thousands of dollars for GS-441524 after their cats were diagnosed with FIPV. All of them said they were surprised by the news of the FDA’s investigation, and said they were given various reasons for why the drug was so expensive to acquire.

One customer from Texas, whose cat Seth began his regimen in July of 2020, told PITB she doesn’t regret spending the money to cure Seth, but she “can see how the people saw our desperate situation and took advantage of us.” She was told prices were at a premium because of scarcity.

“It was a very stressful time for us, and every time we needed to refill, they charged us more,” she said. “They knew we couldn’t say no.”

Another woman, whose kitten was diagnosed with FIPV in 2021, “was told that the prices were set because they ensure the medication was purchased from a trusted source.”

As a college student at the time, she used her savings and crowdfunded the other half, paying more than $5,000 for her kitten’s treatment. She said she doesn’t think the administrators of the group were ripping her off, since they had FIP cats of their own, and likely didn’t know the importers were making huge profits. She trusted the seller — who was not Ross or Randall — because the group vouched for that person, assuring her they supplied real pills.

“Of course, I don’t think this is a valid justification for hiking up prices up to 16x the amount,” she told PITB, “but I’m sincerely hoping the individual [accused by the FDA] had a valid reason for setting the prices that she did.”

Others paid even more exorbitant prices: a British woman we interviewed for a story about FIPV in 2022 said she paid about £7,000, or $9,400 at the time.

FDA investigators said they intercepted shipments from China and Hong Kong disguised as COVID masks, cat shampoo and chewable medicine for pets, and the Oregonian report says the shipments were listed as “essential oils” and “beauty products” in import documents.

Randall and Ross have not been charged criminally, but they are now targets of a civil asset forfeiture case:

“The government seized five of Randall’s bank and brokerage accounts and her 2022 Tesla Model Y car last year based on a warrant signed by a federal magistrate judge in Oregon.

The warrant identified the bank accounts and car as proceeds from the “crime of smuggling” and subject to forfeiture, according to the affidavit. It also alleged Randall, now 35, used the proceeds to buy several properties, including a ranch in Leander, Texas, in July 2021.”

While the FDA’s affidavit went into detail regarding Randall’s earnings, it describes shipments sent to Ross but does not specify how much she may have made in profit. An attorney for Randall told The Oregonian that the Texas woman will fight the civil asset forfeiture.

The illegal market for GS-441524 exists because the drug’s creator, Gilead Sciences of California, declined to submit it to the FDA for approval. That’s because it’s chemically similar to another drug the company makes, remdesivir, which was floated as a possible treatment for COVID-19. The company was worried any snags in a potential approval process for GS-441524 would also ensnare remdesivir, according to reports, putting the latter drug in limbo during the pandemic.

Now that the pandemic has retreated to much lower levels of infection and death, it’s not clear if Gilead Sciences will reconsider its FIPV medication, but there may be hope in the form of alternate treatments. A report from the American Animal Hospital Association (AAHA) says scientists at the University of California-Davis and UC San Diego are working on several promising therapies, including a potential treatment using CRISPR gene-editing technology.

But until another cure or treatment passes trials and earns FDA approval — a process that could take years — people with FIPV-diagnosed cats remain at the mercy of strangers on the internet, spending thousands of dollars per regimen and hoping the drugs they buy are the real deal.